Sector | Trading | Compare with Sector peers |
Industry | Trading | Compare with Industry peers |
Website | http://www.enterohealthcare.com | |
Market Cap | 5,020.05 Cr. | |
Enterprise Value(EV) | 5,287.52 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -2.66 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-03 |
Industry PE | 65.05 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 359.88 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 3.21 | Calculated using Price: 1,154.20 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 4.35 Cr. | 43,493,767 Shares |
FaceValue | 10 | |
About Entero Healthcare Solutions Ltd. | ||
Entero Healthcare Solutions is one of India's largest and fastest growing healthcare products distribution platforms. The company offers both demand generation and demand fulfilment solutions to healthcare product manufacturers. |
1 Day |
|
-1.53% |
1 Week |
|
+3.48% |
1 Month |
|
+16.16% |
3 Month |
|
|
6 Month |
|
|
1 Year |
|
|
2 Year |
|
|
5 Year |
|
|
10 Year |
|
3 years | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 0 | 0 | 0 | |
Return on Capital Employed (%) | 1.47 | 1.24 | 4.99 | |
Return on Assets (%) | -1.84 | -3.01 | -0.91 |
Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Shh. Funds | 485 | 561 | 595 | |
Non Curr. Liab. | 57 | 100 | 85 | |
Curr. Liab. | 289 | 462 | 624 | |
Minority Int. | 2 | 2 | 3 | |
Equity & Liab. | 833 | 1,125 | 1,307 | |
Non Curr. Assets | 201 | 274 | 284 | |
Curr. Assets | 633 | 851 | 1,023 | |
Misc. Exp. not W/O | ||||
Total Assets | 833 | 1,125 | 1,307 |
Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Net Sales | 1,780 | 2,522 | 3,300 | |
Other Income | 4 | 4 | 6 | |
Total Income | 1,784 | 2,527 | 3,306 | |
Total Expenditure | -1,758 | -2,498 | -3,236 | |
PBIDT | 25 | 29 | 70 | |
Interest | -20 | -29 | -49 | |
Depreciation | -16 | -20 | -24 | |
Taxation | -5 | -10 | -7 | |
Exceptional Items | ||||
PAT | -15 | -29 | -11 | |
Minority Interest | 0 | 0 | 0 | |
Share Associate | ||||
Other Related Items | ||||
Consolidated Net Profit | -16 | -30 | -12 | |
Adjusted EPS | -1,554 | -78 | -28 |
Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | -69 | -35 | -45 | |
Cash Fr. Inv. | -31 | -162 | -49 | |
Cash Fr. Finan. | 89 | 211 | 73 | |
Net Change | -11 | 14 | -21 | |
Cash & Cash Eqvt | 32 | 47 | 25 |
Wed, 24 Apr 2024
Analysts/Institutional Investor Meet/Con. Call Updates Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet |
Fri, 12 Apr 2024
Disclosure under SEBI Takeover Regulations Prabhat Agrawal has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
Wed, 10 Apr 2024
Disclosure under SEBI Takeover Regulations OrbiMed Asia III Mauritius Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
Fri, 26 Apr 2024 |
Closing Below Previous Low |
Close Within 52 Week High Zone |
Closing Below Previous Low for 2 Days |
Making Lower Lows for 2 Days |
High Increase in 1 Month |